Genes with particular expression in the Temporal association areas, layer 1. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Accessory olfactory bulb. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Anterior olfactory nucleus, dorsal part. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Accessory olfactory bulb, glomerular layer. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Accessory olfactory bulb, mitral layer. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Temporal association areas, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Posterolateral visual area, layer 2/3. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Orbital area, lateral part, layer 2/3. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Orbital area, lateral part, layer 1. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary somatosensory area, lower limb, layer 6a. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the posteromedial visual area, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary somatosensory area, lower limb, layer 6b. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the posteromedial visual area, layer 5. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Orbital area, lateral part, layer 5. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Orbital area, lateral part. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Posterolateral visual area, layer 1. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Ectorhinal area/Layer 1. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary motor area, Layer 6a. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Lateral visual area, layer 2/3. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary somatosensory area, barrel field, layer 6b. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Temporal association areas, layer 2/3. Data represent fold expression difference in structure versus grey matter average expression.
Transcriptome sequencing from the SCNs of mice (C57BL/6J) entrained for 4 weeks to 22 h and 24 h d maintained for a week in darkness, and then killed at CT4 for each mouse. Supplementary table 3: List of the genomic regions hypermethylated in ST and Score.
Authors:
Azzi A, Dallmann R, Casserly A, Rehrauer H, Patrignani A, Maier B, Kramer A, Brown SA
Here, female High Drinking in the Dark (HDID) mice were stereotaxically injected with 0.5uL rAAV2/5-CMV-Cre-GFP and 0.5uL rAAV2-hSyn-DIO-hM3Dq-mCherry bilaterally into the NAc. A Drinking in the Dark (DID) experiment lasting 6 weeks was carried out with 2 fluid groups (water or ethanol) and 2 treatment groups (VEH/VEH/VEH or VEH/CNO/VEH). Mice were serially treated with vehicle prior to DID during week 1 to establish baseline drinking, CNO (1mg/kg) during weeks 2-5 to measure the effects of chronic treatment, and then mice were treated with vehicle again during week 6 to determine if there were any lasting effects of chronic CNO treatment. This gene set comprises 1,473 genes that were differentially expressed in the nucleus accumbens of ethanol drinking HDID mice treated with vehicle as compared to the water drinking and vehicle treated control group.
Authors:
Darya Y. Pozhidayeva, Sean P. Farris, Calla M. Goeke, Evan J. Firsick, Kayla G. Townsley, Marina Guizzetti, and Angela R. Ozburn
Here, female High Drinking in the Dark (HDID) mice were stereotaxically injected with 0.5uL rAAV2/5-CMV-Cre-GFP and 0.5uL rAAV2-hSyn-DIO-hM3Dq-mCherry bilaterally into the NAc. A Drinking in the Dark (DID) experiment lasting 6 weeks was carried out with 2 fluid groups (water or ethanol) and 2 treatment groups (VEH/VEH/VEH or VEH/CNO/VEH). Mice were serially treated with vehicle prior to DID during week 1 to establish baseline drinking, CNO (1mg/kg) during weeks 2-5 to measure the effects of chronic treatment, and then mice were treated with vehicle again during week 6 to determine if there were any lasting effects of chronic CNO treatment. This gene set comprises 688 genes that were uniquely differentially expressed in the nucleus accumbens of only ethanol drinking HDID mice treated with vehicle as compared to the water drinking and vehicle treated control group.
Authors:
Darya Y. Pozhidayeva, Sean P. Farris, Calla M. Goeke, Evan J. Firsick, Kayla G. Townsley, Marina Guizzetti, and Angela R. Ozburn
GeneWeaver